Ninety One UK Ltd cut its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 46.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 179,764 shares of the financial services provider's stock after selling 157,661 shares during the period. Ninety One UK Ltd's holdings in CME Group were worth $47,095,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors also recently added to or reduced their stakes in CME. BlackRock Inc. bought a new stake in shares of CME Group during the second quarter worth approximately $6,749,965,000. Bank of New York Mellon Corp bought a new position in CME Group in the second quarter valued at approximately $867,313,000. Alphabet Inc. bought a new position in CME Group in the second quarter valued at approximately $769,376,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in CME Group in the second quarter valued at approximately $629,771,000. Finally, Bank of America Corp DE acquired a new stake in CME Group during the 2nd quarter worth $622,679,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.
CME Group Trading Up 0.7%
Shares of CME stock traded up $2.07 on Thursday, reaching $287.66. The company had a trading volume of 698,158 shares, compared to its average volume of 2,510,764. The stock has a market cap of $103.44 billion, a PE ratio of 24.45, a PEG ratio of 3.64 and a beta of 0.24. The company has a 50-day moving average of $273.01 and a 200-day moving average of $270.63. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16.
CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.08. The business had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. CME Group's quarterly revenue was up .8% compared to the same quarter last year. During the same quarter last year, the firm earned $2.96 EPS. On average, equities analysts forecast that CME Group Inc. will post 12.29 earnings per share for the current year.
CME Group Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th were paid a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 1.8%. The ex-dividend date of this dividend was Wednesday, September 9th. CME Group's dividend payout ratio is presently 44.11%.
Analyst Ratings Changes
Several analysts have commented on CME shares. Morgan Stanley upped their target price on shares of CME Group from $330.00 to $337.00 and gave the company an "overweight" rating in a research report on Friday, October 9th. Barclays increased their price target on CME Group from $270.00 to $281.00 and gave the company an "equal weight" rating in a research note on Wednesday, October 7th. Wells Fargo & Company raised their price target on CME Group from $301.00 to $315.00 and gave the stock an "overweight" rating in a research report on Wednesday. Keefe, Bruyette & Woods raised CME Group from a "market perform" rating to an "outperform" rating and set a $305.00 price objective for the company in a research note on Thursday, June 18th. Finally, JPMorgan Chase & Co. lifted their price objective on CME Group from $249.00 to $250.00 and gave the stock an "underweight" rating in a research note on Thursday, July 23rd. Nine analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $292.94.
Read Our Latest Report on CME
Insiders Place Their Bets
In other news, Director Elizabeth A. Cook sold 500 shares of the business's stock in a transaction on Monday, September 14th. The shares were sold at an average price of $280.11, for a total value of $140,055.00. Following the completion of the transaction, the director owned 17,916 shares of the company's stock, valued at $5,018,450.76. The trade was a 2.72% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Terrence A. Duffy sold 15,000 shares of the company's stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $274.44, for a total transaction of $4,116,600.00. Following the completion of the sale, the chief executive officer owned 40,630 shares of the company's stock, valued at approximately $11,150,497.20. This represents a 26.96% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 0.30% of the company's stock.
About CME Group
(
Free Report)
CME Group Inc operates global derivatives marketplaces that enable customers to manage risk and trade futures and options contracts. Its exchanges offer products linked to interest rates, equity indexes, foreign currencies, agricultural commodities, energy, metals and other asset classes.
The company also provides central counterparty clearing, settlement and related risk-management services for transactions conducted on its markets. In addition, CME Group offers market data, benchmark products and technology services that support trading, analysis and connectivity for financial institutions, businesses, professional traders and other market participants.
CME Group's history includes the Chicago Board of Trade, founded in 1848, and the Chicago Mercantile Exchange, established in 1898.
Featured Articles
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
